BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9349569)

  • 1. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
    J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI; Musachio JL; Kellar KJ
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites.
    Ulrich YM; Hargreaves KM; Flores CM
    Neuropharmacology; 1997 Aug; 36(8):1119-25. PubMed ID: 9294978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
    Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain.
    Miao H; Liu C; Bishop K; Gong ZH; Nordberg A; Zhang X
    J Neurochem; 1998 Feb; 70(2):752-62. PubMed ID: 9453571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
    Han ZY; Zoli M; Cardona A; Bourgeois JP; Changeux JP; Le Novère N
    J Comp Neurol; 2003 Jun; 461(1):49-60. PubMed ID: 12722104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine.
    Dávila-García MI; Houghtling RA; Qasba SS; Kellar KJ
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):14-23. PubMed ID: 10095073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S; Ahtee L; Tuominen RK
    Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord.
    Hellström-Lindahl E; Gorbounova O; Seiger A; Mousavi M; Nordberg A
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):147-60. PubMed ID: 9693793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
    Perry DC; Kellar KJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1030-4. PubMed ID: 7473129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ; Meinerz NM; Drago J; Collins AC
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W; Gillberg PG; Svensson AL; Nordberg A
    Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.
    Jacobs I; Anderson DJ; Surowy CS; Puttfarcken PS
    Neuropharmacology; 2002 Oct; 43(5):847-56. PubMed ID: 12384170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.